|
James J. Collins (June 26, 1965) is an American bioengineer, and the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. He is one of the founders of the emerging field of synthetic biology, and a pioneering researcher in systems biology, having made fundamental discoveries regarding the actions of antibiotics and the emergence of antibiotic resistance.〔 〕 == Biography == Collins received a bachelor's degree in Physics (summa cum laude; class valedictorian) from the College of the Holy Cross in 1987 and a doctorate in Medical Engineering from the University of Oxford in 1990. From 1987 to 1990, he was a Rhodes Scholar. Currently, Collins is the Henri Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Collins is also a core founding faculty member of the (Wyss Institute for Biologically Inspired Engineering ) at Harvard University, an Institute Member of the Broad Institute at MIT and Harvard, and a Visiting Professor in the Department of Systems Biology at Harvard Medical School. From 1990 to 2014, he was on the faculty at Boston University, where he was a (William F. Warren Distinguished Professor ), a University Professor, Professor of Biomedical Engineering, and Co-Director of the (Center for BioDynamics ) and Director of the Center of Synthetic Biology. Collins' scientific accomplishments have been recognized by numerous awards, including the (NIH Director's Pioneer Award ), the (Ellison Medical Foundation Senior Scholar Award in Aging ), the (inaugural Anthony J. Drexel $100,000 Exceptional Achievement Award ), the Lagrange Prize from the CRT Foundation in Italy, and being selected for Technology Review's inaugural TR100 - 100 young innovators who will shape the future of technology - and the Scientific American 50 - the top 50 outstanding leaders in science and technology. He is also a Fellow of the American Physical Society, the Institute of Physics, and the American Institute for Medical and Biological Engineering. In 2003, he received a MacArthur Foundation "Genius Award",〔 becoming the first bioengineer to receive this honor. Collins' award citation noted, "Throughout his research, Collins demonstrates a proclivity for identifying abstract principles that underlie complex biological phenomena and for using these concepts to solve concrete, practical problems.". He was also honored as a Medical All-Star by the Boston Red Sox, and threw out the (first pitch ) at a Red Sox game in Fenway Park. Collins is an elected member of the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the American Academy of Arts and Sciences, as well as a charter fellow of the National Academy of Inventors. Collins is also a gifted and committed teacher. He has won numerous teaching awards at Boston University, including the Biomedical Engineering Teacher of the Year Award, the College of Engineering Professor of the Year Award, and the Metcalf Cup and Prize for Excellence in Teaching, which is the highest teaching honor awarded by Boston University. Collins has been involved with a number of start-up companies, and his inventions and technologies have been licensed by several biotech and medical device companies. Collins currently chairs the Scientific Advisory Board (SAB) of (Sample6 Technologies ), Synlogic and (EnBiotix ), and serves on the SAB of Joule Unlimited, Agilis Biotherapeutics, Seres Health, enEvolv, Symbiota and Excel Medical Ventures. Additionally, he has served on the SAB of Mannkind Corporation (Nasdaq: MNKD), Codon Devices, Selventa, Gene Network Sciences, Epitome Biosystems, Afferent Corp, Cellicon Biotechnologies, Synereca Pharmaceuticals, LifeWave Ltd, PureTech Ventures and Bios Group Inc. Collins ran track and cross country at Holy Cross (he was a 4:17 miler), and earned a blue playing for the varsity basketball team at the University of Oxford. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「James Collins (bioengineer)」の詳細全文を読む スポンサード リンク
|